SCHEMBL30382155

SCHEMBL30382155

Nc1ncnc2c1ccn2[C@@H]1O[C@H]([C@H](O)c2ccc(Cl)c(F)c2)[C@@H](O)[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 1.00
▸ WDR77 Q9BQA1 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21391701 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18026294 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL21413929 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL29806232 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18026039 0.92 PRMT5 (0.85) PRMT5WDR77
SCHEMBL18026086 0.92 PRMT5 (0.85) PRMT5WDR77
SCHEMBL21413926 0.92 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18009773 0.92 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18205031 0.92 PRMT5 (1.00) PRMT5WDR77
SCHEMBL19696639 0.92 PRMT5 (1.00) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116356032-A Assay mixtures for predicting the sensitivity of PRMT5 inhibitors to treatment of tumors 浙江省肿瘤医院 2023-06-30 — — CN claimed
CN-116211869-A Pharmaceutical mixture containing DNA damage repair inhibitor, mixing method and application 浙江省肿瘤医院 2023-06-06 — — CN claimed
CN-116196415-A Mixed formulations for sensitizing PD-1 antibodies and methods of use thereof 浙江省肿瘤医院 2023-06-02 — — CN claimed
CN-116211869-B Pharmaceutical mixture containing DNA damage repair inhibitor, mixing method and application 浙江省肿瘤医院 2023-08-01 — — CN disclosed
CN-116196415-B Mixed formulations for sensitizing PD-1 antibodies and methods of use thereof 浙江省肿瘤医院 2023-08-01 — — CN disclosed
CN-116356032-A Assay mixtures for predicting the sensitivity of PRMT5 inhibitors to treatment of tumors 浙江省肿瘤医院 2023-06-30 — — CN disclosed
CN-116211869-A Pharmaceutical mixture containing DNA damage repair inhibitor, mixing method and application 浙江省肿瘤医院 2023-06-06 — — CN disclosed
CN-116196415-A Mixed formulations for sensitizing PD-1 antibodies and methods of use thereof 浙江省肿瘤医院 2023-06-02 — — CN disclosed
Send feedback